Intravascular large B-cell lymphoma: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:
{{SK}} Intravascular lymphomatosis; Malignant angioendotheliomatosis;  Intravascular lymphoma; Angiotropic large-cell lymphoma; Angiotropic lymphoma; IVLBCL
{{SK}} Intravascular lymphomatosis; Malignant angioendotheliomatosis;  Intravascular lymphoma; Angiotropic large-cell lymphoma; Angiotropic lymphoma; IVLBCL
== Overview ==
== Overview ==
[[Intravascular large B-cell lymphoma]] is a very rare subtype of [[diffuse large B-cell lymphoma]] (DLBCL). It is also considered a distinct type of [[non-Hodgkin lymphoma]] (NHL) in the World Health Organization ([[WHO]]) classification system. Intravascular large B-cell lymphoma affects small blood vessels.  It is a rare and aggressive variant of intravascular proliferation of clonal [[lymphocytes]] with little to no parenchymal involvement. Based on the clinical presentation, intravascular large B-cell lymphoma may be classified into either Western variant or Asian variant. On microscopic histopathological analysis, diffuse infiltrate of large atypical cells with irregular nuclear contours, vesicular chromatin, and occasional prominent nucleoli  are characteristic findings of intravascular large b-cell lymphoma. The incidence of intravascular large B-cell lymphoma increases with age; the median age at diagnosis is 67 years. Intravascular large B-cell lymphoma affects men and women equally. People with this type of lymphoma often have a poor prognosis. Symptoms of the intravascular large B-cell lymphoma include [[fever]], [[weight loss]], [[night sweats]], chest pain, abdominal pain, bone pain, and painless swellings in the neck, axilla, groin, thorax, and abdomen. Lymph node biopsy is diagnostic of intravascular large B-cell lymphoma. [[CT]], [[MRI]], and [[PET]] scan may be helpful in the diagnosis of intravascular large B-cell lymphoma. The predominant therapy for intravascular large B-cell lymphoma  is [[chemotherapy]]. Adjunctive [[radiotherapy]] may be required.
[[Intravascular large B-cell lymphoma]] is a very rare subtype of [[diffuse large B-cell lymphoma]] (DLBCL). It is also considered a distinct type of [[non-Hodgkin lymphoma]] (NHL) in the World Health Organization ([[WHO]]) classification system. Intravascular large B-cell lymphoma affects small blood vessels.  It is a rare and aggressive variant of intravascular proliferation of clonal [[lymphocytes]] with little to no [[parenchymal]] involvement. Based on the clinical presentation, intravascular large B-cell lymphoma may be classified into either Western variant or Asian variant. On microscopic histopathological analysis, [[diffuse]] infiltrate of large atypical cells with irregular nuclear contours, vesicular chromatin, and occasional prominent nucleoli  are characteristic findings of intravascular large b-cell lymphoma. The incidence of intravascular [[large B-cell lymphoma]] increases with age; the median age at diagnosis is 67 years. Intravascular large B-cell [[lymphoma]] affects men and women equally. People with this type of [[lymphoma]] often have a poor prognosis. Symptoms of the intravascular large B-cell lymphoma include [[fever]], [[weight loss]], [[night sweats]], chest pain, abdominal pain, bone pain, and painless swellings in the neck, axilla, groin, thorax, and abdomen. [[Lymph node]] biopsy is diagnostic of intravascular large B-cell lymphoma. [[CT]], [[MRI]], and [[PET]] scan may be helpful in the diagnosis of intravascular large B-cell lymphoma. The predominant therapy for intravascular large B-cell lymphoma  is [[chemotherapy]]. Adjunctive [[radiotherapy]] may be required.


==Classification==
==Classification==

Revision as of 23:56, 16 September 2019

WikiDoc Resources for Intravascular large B-cell lymphoma

Articles

Most recent articles on Intravascular large B-cell lymphoma

Most cited articles on Intravascular large B-cell lymphoma

Review articles on Intravascular large B-cell lymphoma

Articles on Intravascular large B-cell lymphoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Intravascular large B-cell lymphoma

Images of Intravascular large B-cell lymphoma

Photos of Intravascular large B-cell lymphoma

Podcasts & MP3s on Intravascular large B-cell lymphoma

Videos on Intravascular large B-cell lymphoma

Evidence Based Medicine

Cochrane Collaboration on Intravascular large B-cell lymphoma

Bandolier on Intravascular large B-cell lymphoma

TRIP on Intravascular large B-cell lymphoma

Clinical Trials

Ongoing Trials on Intravascular large B-cell lymphoma at Clinical Trials.gov

Trial results on Intravascular large B-cell lymphoma

Clinical Trials on Intravascular large B-cell lymphoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Intravascular large B-cell lymphoma

NICE Guidance on Intravascular large B-cell lymphoma

NHS PRODIGY Guidance

FDA on Intravascular large B-cell lymphoma

CDC on Intravascular large B-cell lymphoma

Books

Books on Intravascular large B-cell lymphoma

News

Intravascular large B-cell lymphoma in the news

Be alerted to news on Intravascular large B-cell lymphoma

News trends on Intravascular large B-cell lymphoma

Commentary

Blogs on Intravascular large B-cell lymphoma

Definitions

Definitions of Intravascular large B-cell lymphoma

Patient Resources / Community

Patient resources on Intravascular large B-cell lymphoma

Discussion groups on Intravascular large B-cell lymphoma

Patient Handouts on Intravascular large B-cell lymphoma

Directions to Hospitals Treating Intravascular large B-cell lymphoma

Risk calculators and risk factors for Intravascular large B-cell lymphoma

Healthcare Provider Resources

Symptoms of Intravascular large B-cell lymphoma

Causes & Risk Factors for Intravascular large B-cell lymphoma

Diagnostic studies for Intravascular large B-cell lymphoma

Treatment of Intravascular large B-cell lymphoma

Continuing Medical Education (CME)

CME Programs on Intravascular large B-cell lymphoma

International

Intravascular large B-cell lymphoma en Espanol

Intravascular large B-cell lymphoma en Francais

Business

Intravascular large B-cell lymphoma in the Marketplace

Patents on Intravascular large B-cell lymphoma

Experimental / Informatics

List of terms related to Intravascular large B-cell lymphoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Synonyms and keywords: Intravascular lymphomatosis; Malignant angioendotheliomatosis; Intravascular lymphoma; Angiotropic large-cell lymphoma; Angiotropic lymphoma; IVLBCL

Overview

Intravascular large B-cell lymphoma is a very rare subtype of diffuse large B-cell lymphoma (DLBCL). It is also considered a distinct type of non-Hodgkin lymphoma (NHL) in the World Health Organization (WHO) classification system. Intravascular large B-cell lymphoma affects small blood vessels. It is a rare and aggressive variant of intravascular proliferation of clonal lymphocytes with little to no parenchymal involvement. Based on the clinical presentation, intravascular large B-cell lymphoma may be classified into either Western variant or Asian variant. On microscopic histopathological analysis, diffuse infiltrate of large atypical cells with irregular nuclear contours, vesicular chromatin, and occasional prominent nucleoli are characteristic findings of intravascular large b-cell lymphoma. The incidence of intravascular large B-cell lymphoma increases with age; the median age at diagnosis is 67 years. Intravascular large B-cell lymphoma affects men and women equally. People with this type of lymphoma often have a poor prognosis. Symptoms of the intravascular large B-cell lymphoma include fever, weight loss, night sweats, chest pain, abdominal pain, bone pain, and painless swellings in the neck, axilla, groin, thorax, and abdomen. Lymph node biopsy is diagnostic of intravascular large B-cell lymphoma. CT, MRI, and PET scan may be helpful in the diagnosis of intravascular large B-cell lymphoma. The predominant therapy for intravascular large B-cell lymphoma is chemotherapy. Adjunctive radiotherapy may be required.

Classification

Based on the clinical presentation, intravascular large B-cell lymphoma may be classified into either Western variant or Asian variant.

Intravascular large B-cell lymphoma classification
Name Description
Western variant
  • Western variant characterized by symptoms related to the main organ involved, predominantly neurological or cutaneous
Asian variant
  • Asian variant in which the patients present with multi-organ failure, hepatosplenomegaly, pancytopenia, and hemophagocytic syndrome.
  • This is an aggressive lymphoma which responds poorly to chemotherapy.
  • The poor prognosis reflects in part frequent delays in diagnosis because of a lack of detectable tumor masses.

Pathophysiology

Intravascular large B-cell lymphoma is characterized by a massive intravascular proliferation of atypical mononuclear cells which lodged in the lumina of small or intermediate vessels in many organs. The neoplastic lymphoid cells are large with prominent nucleoli and frequent mitotic figures. Fibrin thrombi, haemorrhage and necrosis may be seen.

Microscopic Pathology

On microscopic histopathological analysis, diffuse infiltrate of large atypical cells with irregular nuclear contours, vesicular chromatin, and occasional prominent nucleoli are characteristic findings of intravascular large b-cell lymphoma.

Causes

There are no established causes for intravascular large B-cell lymphoma.

Differentiating type page name here from other Diseases

Intravascular large B-cell lymphoma must be differentiated from other diseases such as:

Epidemiology and Demographics

Age

The incidence of intravascular large B-cell lymphoma increases with age; the median age at diagnosis is 67 years.[1]

Gender

Intravascular large B-cell lymphoma affects men and women equally.[1]

Risk Factors

There are no established risk factors for intravascular large B-cell lymphoma.

Natural History, Complications and Prognosis

  • Intravascular large B-cell lymphoma usually affects the small blood vessels in many organs, including: central nervous system, kidneys, lungs, and skin. However, almost any site can be affected.
  • People with intravascular large B-cell lymphoma have a variety of symptoms. The symptoms will depend on the tissue or organ affected when the blood vessels become occluded. This type of lymphoma is often difficult to diagnose because the symptoms can be so varied.
  • Intravascular large B-cell lymphoma is a fast-growing (aggressive) lymphoma.
  • People with this type of lymphoma often have a poor prognosis.
  • People with this type of lymphoma can also develop a very serious condition where certain parts of the immune system are activated (hemophagocytic syndrome).[1]
  • Hemophagocytic syndrome causes:

Diagnosis

Staging

Staging for Intravascular large B-cell lymphoma is provided in the following table:[2]

Revised staging system for primary nodal lymphomas (Lugano classification)
Stage Involvement Extranodal (E) status
Limited
Stage I One node or a group of adjacent nodes Single extranodal lesions without nodal involvement
Stage II Two or more nodal groups on the same side of the diaphragm Stage I or II by nodal extent with limited contiguous extranodal involvement
Stage II bulky II as above with "bulky" disease Not applicable
Advanced
Stage III Nodes on both sides of the diaphragm; nodes above the diaphragm with spleen involvement Not applicable
Stage IV Additional noncontiguous extralymphatic involvement Not applicable

Symptoms

People with intravascular large B-cell lymphoma have a variety of symptoms. The symptoms will depend on the tissue or organ affected when the blood vessels become occluded. This type of lymphoma is often difficult to diagnose because the symptoms can be so varied. Most common symptoms of the intravascular large B-cell lymphoma include:[1]

Physical Examination

Vitals

Skin

  • Skin rash

HEENT

Thorax

Abdomen

Extremities

Intravascular large B-cell lymphoma clinical features based on organ involvement
Organ Involved Clinical features
Central nervous system
Cutaneous Involvement
  • Maculopapular eruptions, nodules, plaques, tumors, hyperpigmented patches, palpable purpura, ulcers, and infiltrative “peau d’orange”

Laboratory Findings

Laboratory tests for intravascular large B-cell lymphoma include:[1]

Biopsy

Lymph node biopsy is diagnostic of intravascular large B-cell lymphoma.

Other Imaging Findings

CT, MRI, and PET scan may be helpful in the diagnosis of intravascular large B-cell lymphoma.

Treatment

Medical Therapy

Treatment of intravascular large B-cell lymphoma[3]
Therapy Description
Chemotherapy
  • Combination therapy :
Radiation therapy

References

  1. 1.0 1.1 1.2 1.3 1.4 Intravascular large B-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf5ae3e27c3994bd54a7/. Accessed on March 09, 2016
  2. Cheson, Bruce D.; Fisher, Richard I.; Barrington, Sally F.; Cavalli, Franco; Schwartz, Lawrence H.; Zucca, Emanuele; Lister, T. Andrew; Alliance, Australasian Leukaemia and Lymphoma Group; Eastern Cooperative Oncology Group; European Mantle Cell Lymphoma Consortium; Italian Lymphoma Foundation; European Organisation for Research; Treatment of Cancer/Dutch Hemato-Oncology Group; Grupo Español de Médula Ósea; German High-Grade Lymphoma Study Group; German Hodgkin's Study Group; Japanese Lymphorra Study Group; Lymphoma Study Association; NCIC Clinical Trials Group; Nordic Lymphoma Study Group; Southwest Oncology Group; United Kingdom National Cancer Research Institute (2014-09-20). "Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification". Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 32 (27): 3059–3068. doi:10.1200/JCO.2013.54.8800. ISSN 1527-7755. PMID 25113753.
  3. Intravascular large B-cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/intravascular-large-b-cell-lymphoma/?region=nb. Accessed on March 9, 2016

Related Chapters



Template:WikiDoc Sources